
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
Lue Ping Zhao, Andrew Fioré-Gartland, Lindsay N. Carpp, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0226803-e0226803
Open Access | Times Cited: 23
Lue Ping Zhao, Andrew Fioré-Gartland, Lindsay N. Carpp, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0226803-e0226803
Open Access | Times Cited: 23
Showing 23 citing articles:
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes, Kevin Wiehe, Persephone Borrow, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 142-158
Open Access | Times Cited: 206
Barton F. Haynes, Kevin Wiehe, Persephone Borrow, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 142-158
Open Access | Times Cited: 206
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions
Tiza L Nguni, Caroline Chasara, Zaza M. Ndhlovu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 121
Tiza L Nguni, Caroline Chasara, Zaza M. Ndhlovu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 121
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O. Saunders, Norbert Pardi, Robert Parks, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Kevin O. Saunders, Norbert Pardi, Robert Parks, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach
Miyssa I. Abdelmageed, Abdelrahman H. Abdelmoneim, Mujahed I. Mustafa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 53
Miyssa I. Abdelmageed, Abdelrahman H. Abdelmoneim, Mujahed I. Mustafa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 53
Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk
Zoe Moodie, One Dintwe, Sheetal Sawant, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 2, pp. 246-257
Open Access | Times Cited: 30
Zoe Moodie, One Dintwe, Sheetal Sawant, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 2, pp. 246-257
Open Access | Times Cited: 30
The Question of HIV Vaccine: Why Is a Solution Not Yet Available?
Martina Libera, Valeria Caputo, Giulia Laterza, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-20
Open Access | Times Cited: 3
Martina Libera, Valeria Caputo, Giulia Laterza, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-20
Open Access | Times Cited: 3
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O. Saunders, Norbert Pardi, Robert Parks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 20
Kevin O. Saunders, Norbert Pardi, Robert Parks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 20
An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19
Lucy Chimoyi, Kavindhran Velen, Gavin Churchyard, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243707-e0243707
Open Access | Times Cited: 18
Lucy Chimoyi, Kavindhran Velen, Gavin Churchyard, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243707-e0243707
Open Access | Times Cited: 18
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
Barbara Ensoli, Sonia Moretti, Alessândra Borsetti, et al.
Archives of Virology (2021) Vol. 166, Iss. 11, pp. 2955-2974
Open Access | Times Cited: 16
Barbara Ensoli, Sonia Moretti, Alessândra Borsetti, et al.
Archives of Virology (2021) Vol. 166, Iss. 11, pp. 2955-2974
Open Access | Times Cited: 16
A tale of four studies: HIV vaccine immunogenicity and efficacy in clinical trials
Susan Zolla‐Pazner, Nelson L. Michael, Jérôme H. Kim
The Lancet HIV (2021) Vol. 8, Iss. 7, pp. e449-e452
Open Access | Times Cited: 15
Susan Zolla‐Pazner, Nelson L. Michael, Jérôme H. Kim
The Lancet HIV (2021) Vol. 8, Iss. 7, pp. e449-e452
Open Access | Times Cited: 15
Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine
Mona Sadat Larijani, Amitis Ramezani, Maryam Mashhadi Abolghasem Shirazi, et al.
Virus Research (2021) Vol. 298, pp. 198403-198403
Open Access | Times Cited: 11
Mona Sadat Larijani, Amitis Ramezani, Maryam Mashhadi Abolghasem Shirazi, et al.
Virus Research (2021) Vol. 298, pp. 198403-198403
Open Access | Times Cited: 11
Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4+ T Cells That Correlated with Reduced Risk of Infection in RV144 Trial
Kristen W. Cohen, Yuan Tian, Casey Thayer, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 3, pp. 526-534
Open Access | Times Cited: 7
Kristen W. Cohen, Yuan Tian, Casey Thayer, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 3, pp. 526-534
Open Access | Times Cited: 7
Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis
Jonathan Nye, M. Patricia D‘Souza, Dale J. Hu, et al.
Heliyon (2021) Vol. 7, Iss. 1, pp. e06005-e06005
Open Access | Times Cited: 10
Jonathan Nye, M. Patricia D‘Souza, Dale J. Hu, et al.
Heliyon (2021) Vol. 7, Iss. 1, pp. e06005-e06005
Open Access | Times Cited: 10
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
Yunda Huang, Yuanyuan Zhang, Kelly E. Seaton, et al.
EBioMedicine (2022) Vol. 84, pp. 104271-104271
Open Access | Times Cited: 6
Yunda Huang, Yuanyuan Zhang, Kelly E. Seaton, et al.
EBioMedicine (2022) Vol. 84, pp. 104271-104271
Open Access | Times Cited: 6
Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
William D. Tolbert, Verna Van, Rebekah Sherburn, et al.
mBio (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 6
William D. Tolbert, Verna Van, Rebekah Sherburn, et al.
mBio (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 6
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial
Nigel Garrett, One Dintwe, Cynthia L. Monaco, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2024) Vol. 96, Iss. 4, pp. 350-360
Open Access
Nigel Garrett, One Dintwe, Cynthia L. Monaco, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2024) Vol. 96, Iss. 4, pp. 350-360
Open Access
Progresses and Challenges in HIV Vaccine
Subrat Kumar, Sunil Kumar Jada, Subhra Subhadra, et al.
(2024), pp. 89-125
Closed Access
Subrat Kumar, Sunil Kumar Jada, Subhra Subhadra, et al.
(2024), pp. 89-125
Closed Access
Comparative Analysis of IMT-P8 and LDP12 Cell-Penetrating Peptides in Increasing Immunostimulatory Properties of HIV-1 Nef-MPER-V3 Antigen
Seyed Mehdi Sadat, Shekoufa Jahedian, Sahar Sabaghzadeh, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 10, pp. 818-826
Closed Access
Seyed Mehdi Sadat, Shekoufa Jahedian, Sahar Sabaghzadeh, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 10, pp. 818-826
Closed Access
Research productivity and collaboration of the NIH-funded HIV Vaccine Trials Network: a bibliometric analysis
Jonathan Nye, M. Patricia D‘Souza, Dale J. Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Jonathan Nye, M. Patricia D‘Souza, Dale J. Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Human Immunodeficiency Virus Vaccines
Barton F. Haynes, Kevin Wiehe, Priyamvada Acharya, et al.
Elsevier eBooks (2023), pp. 458-483.e15
Closed Access
Barton F. Haynes, Kevin Wiehe, Priyamvada Acharya, et al.
Elsevier eBooks (2023), pp. 458-483.e15
Closed Access
Influence of HIV‐1 V2 sequence variability on bacterial translocation in antiretroviral naïve HIV‐1 infected patients
Flavia Balena, Davide Fiore Bavaro, Anna Rita Volpe, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 12, pp. 3271-3278
Closed Access
Flavia Balena, Davide Fiore Bavaro, Anna Rita Volpe, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 12, pp. 3271-3278
Closed Access
T helper 2 transcriptional profile predicts single-cell HIV envelope-specific polyfunctional CD4+ T cells correlated with reduced risk of infection in RV144 trial
Kristen W. Cohen, Yuan Tian, Casey Thayer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Kristen W. Cohen, Yuan Tian, Casey Thayer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access